+データを開く
-基本情報
登録情報 | データベース: PDB / ID: 6vk2 | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
タイトル | NMR solution structure of Grb2-SH2 domain at pH 7 | |||||||||||||||
要素 | Growth factor receptor-bound protein 2 | |||||||||||||||
キーワード | CELL CYCLE / Grb2 / SH2 domain / dynamics | |||||||||||||||
機能・相同性 | 機能・相同性情報 guanyl-nucleotide exchange factor adaptor activity / Grb2-EGFR complex / branching involved in labyrinthine layer morphogenesis / STAT5 Activation / COP9 signalosome / neurotrophin TRKA receptor binding / Activated NTRK2 signals through PI3K / MET receptor recycling / transmembrane receptor protein tyrosine kinase adaptor activity / Signaling by cytosolic FGFR1 fusion mutants ...guanyl-nucleotide exchange factor adaptor activity / Grb2-EGFR complex / branching involved in labyrinthine layer morphogenesis / STAT5 Activation / COP9 signalosome / neurotrophin TRKA receptor binding / Activated NTRK2 signals through PI3K / MET receptor recycling / transmembrane receptor protein tyrosine kinase adaptor activity / Signaling by cytosolic FGFR1 fusion mutants / Interleukin-15 signaling / MET activates PTPN11 / MET activates RAP1 and RAC1 / vesicle membrane / Costimulation by the CD28 family / CD28 dependent Vav1 pathway / Signaling by LTK / MET activates PI3K/AKT signaling / Signal regulatory protein family interactions / natural killer cell mediated cytotoxicity / positive regulation of actin filament polymerization / epidermal growth factor receptor binding / Regulation of KIT signaling / PI-3K cascade:FGFR2 / PI-3K cascade:FGFR3 / STAT5 activation downstream of FLT3 ITD mutants / PI-3K cascade:FGFR4 / PI-3K cascade:FGFR1 / endodermal cell differentiation / regulation of MAPK cascade / GRB2:SOS provides linkage to MAPK signaling for Integrins / RHOU GTPase cycle / PI3K events in ERBB2 signaling / PI3K Cascade / RET signaling / SOS-mediated signalling / insulin receptor substrate binding / Activated NTRK3 signals through RAS / Interleukin-3, Interleukin-5 and GM-CSF signaling / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling / fibroblast growth factor receptor signaling pathway / Signalling to RAS / signal transduction in response to DNA damage / RHO GTPases Activate WASPs and WAVEs / GAB1 signalosome / SHC-related events triggered by IGF1R / Activated NTRK2 signals through FRS2 and FRS3 / Role of LAT2/NTAL/LAB on calcium mobilization / Interleukin receptor SHC signaling / Signal attenuation / SHC-mediated cascade:FGFR2 / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / Schwann cell development / SHC-mediated cascade:FGFR4 / Signaling by FGFR4 in disease / Erythropoietin activates RAS / Signaling by CSF3 (G-CSF) / SHC-mediated cascade:FGFR1 / FRS-mediated FGFR2 signaling / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / Signaling by FGFR2 in disease / FRS-mediated FGFR4 signaling / Signaling by FGFR3 in disease / Tie2 Signaling / FRS-mediated FGFR1 signaling / GRB2 events in EGFR signaling / FLT3 Signaling / SHC1 events in EGFR signaling / EGFR Transactivation by Gastrin / Signaling by FLT3 fusion proteins / phosphotyrosine residue binding / Signaling by FGFR1 in disease / myelination / ephrin receptor binding / GRB2 events in ERBB2 signaling / NCAM signaling for neurite out-growth / SHC1 events in ERBB2 signaling / Downstream signal transduction / Constitutive Signaling by Overexpressed ERBB2 / Insulin receptor signalling cascade / FCERI mediated Ca+2 mobilization / insulin-like growth factor receptor signaling pathway / T cell activation / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / InlB-mediated entry of Listeria monocytogenes into host cell / Antigen activates B Cell Receptor (BCR) leading to generation of second messengers / Regulation of signaling by CBL / cellular response to ionizing radiation / Negative regulation of FGFR2 signaling / FCGR3A-mediated phagocytosis / FCERI mediated MAPK activation / Negative regulation of FGFR3 signaling / B cell receptor signaling pathway / Signaling by ERBB2 TMD/JMD mutants / EGFR downregulation 類似検索 - 分子機能 | |||||||||||||||
生物種 | Homo sapiens (ヒト) | |||||||||||||||
手法 | 溶液NMR / na | |||||||||||||||
データ登録者 | Sanches, K. / Caruso, I.P. / Melo, F.A. / Almeida, F.C.L. | |||||||||||||||
資金援助 | ブラジル, 4件
| |||||||||||||||
引用 | ジャーナル: Sci Rep / 年: 2020 タイトル: The dynamics of free and phosphopeptide-bound Grb2-SH2 reveals two dynamically independent subdomains and an encounter complex with fuzzy interactions. 著者: Sanches, K. / Caruso, I.P. / Almeida, F.C.L. / Melo, F.A. #1: ジャーナル: Biomol NMR Assign / 年: 2019 タイトル: NMR assignment of free 1H, 15N and 13C-Grb2-SH2 domain. 著者: Sanches, K. / Caruso, I.P. / Almeida, F.C.L. / Melo, F.A. | |||||||||||||||
履歴 |
|
-構造の表示
構造ビューア | 分子: MolmilJmol/JSmol |
---|
-ダウンロードとリンク
-ダウンロード
PDBx/mmCIF形式 | 6vk2.cif.gz | 609.3 KB | 表示 | PDBx/mmCIF形式 |
---|---|---|---|---|
PDB形式 | pdb6vk2.ent.gz | 512 KB | 表示 | PDB形式 |
PDBx/mmJSON形式 | 6vk2.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
その他 | その他のダウンロード |
-検証レポート
文書・要旨 | 6vk2_validation.pdf.gz | 458.5 KB | 表示 | wwPDB検証レポート |
---|---|---|---|---|
文書・詳細版 | 6vk2_full_validation.pdf.gz | 855.9 KB | 表示 | |
XML形式データ | 6vk2_validation.xml.gz | 96.5 KB | 表示 | |
CIF形式データ | 6vk2_validation.cif.gz | 78.7 KB | 表示 | |
アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/vk/6vk2 ftp://data.pdbj.org/pub/pdb/validation_reports/vk/6vk2 | HTTPS FTP |
-関連構造データ
関連構造データ | |
---|---|
類似構造データ | |
その他のデータベース |
|
-リンク
-集合体
登録構造単位 |
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
1 |
| |||||||||
NMR アンサンブル |
|
-要素
#1: タンパク質 | 分子量: 11204.756 Da / 分子数: 1 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: GRB2, ASH / 発現宿主: Escherichia coli BL21(DE3) (大腸菌) / 株 (発現宿主): BL21(DE3) / 参照: UniProt: P62993 |
---|
-実験情報
-実験
実験 | 手法: 溶液NMR | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NMR実験 |
|
-試料調製
詳細 | タイプ: solution 内容: 200 mM sodium chloride, 20 mM sodium phosphate, 1 mM EDTA, 1 mM PMSF, 5 mM sodium azide, 300 uM [U-100% 13C; U-100% 15N] Grb2-SH2, 90% H2O/10% D2O 詳細: ~300 uM 13C/15N-Grb2-SH2 in buffer 20 mM NaPi pH 7.0 containing 200 mM NaCl, 1.0 mM EDTA, 1.0 mM PMSF, 5.0 mM NaN3, and 10% D2O Label: Grb2-SH2 / 溶媒系: 90% H2O/10% D2O | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
試料 |
| ||||||||||||||||||||||||||||
試料状態 | 詳細: ~300 uM 13C/15N-Grb2-SH2 in buffer 20 mM NaPi pH 7.0 containing 200 mM NaCl, 1.0 mM EDTA, 1.0 mM PMSF, 5.0 mM NaN3, and 10% D2O イオン強度: 138.2 mM / Label: Condition1 / pH: 7 / 圧: 1 atm / 温度: 298 K |
-NMR測定
NMRスペクトロメーター |
|
---|
-解析
NMR software |
| ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 手法: na / ソフトェア番号: 4 | ||||||||||||||||||||||||||||
代表構造 | 選択基準: lowest energy | ||||||||||||||||||||||||||||
NMRアンサンブル | コンフォーマー選択の基準: structures with the lowest energy 計算したコンフォーマーの数: 66317 / 登録したコンフォーマーの数: 20 |